Ignite Creation Date:
2024-05-06 @ 12:44 AM
Last Modification Date:
2024-10-26 @ 10:53 AM
Study NCT ID:
NCT01640444
Status:
COMPLETED
Last Update Posted:
2019-04-11
First Post:
2012-06-13
Brief Title:
Influence of BRAF and PIK3K Status on the Efficacy of 5-FluorouracilLeucovorinOxaliplatin FOLFIRI Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and 3 Circulating Tumor Cells CTC
Sponsor:
Spanish Cooperative Group for the Treatment of Digestive Tumours TTD
Organization:
Spanish Cooperative Group for the Treatment of Digestive Tumours TTD
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11
Completion Date Type:
ACTUAL
First Submit Date:
2012-06-13
First Submit QC Date:
July 10 2012
Study First Post Date:
2012-07-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-10
Last Update Post Date:
2019-04-11
Last Update Post Date Type:
ACTUAL